Cargando…
Are the VAERS-included reactions following the human papillomavirus immunization correlated to the number of vaccine doses?
Autor principal: | Poddighe, Dimitri |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7819373/ https://www.ncbi.nlm.nih.gov/pubmed/33489839 http://dx.doi.org/10.4103/picr.PICR_69_20 |
Ejemplares similares
-
Comment on “Central Demyelinating Diseases After Vaccination Against Hepatitis B Virus: A Disproportionality Analysis Within the VAERS Database”
por: Cohen, Carine, et al.
Publicado: (2018) -
Pityriasis rosea following human papillomavirus vaccination()
por: Drago, Francesco, et al.
Publicado: (2014) -
Investigating safety profiles of human papillomavirus vaccine across group differences using VAERS data and MedDRA
por: Jia, Yuxi, et al.
Publicado: (2019) -
Prevalence of Human Papillomavirus Infection by Number of Vaccine Doses Among US Women
por: Sonawane, Kalyani, et al.
Publicado: (2019) -
Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)
por: Welsh, Kerry J., et al.
Publicado: (2021)